[Ovid] Real-world Outcomes of Ipilimumab Plus Nivolumab Combination Therapy in a Nation-wide Cohort of Advanced Melanoma Patients in the Netherlands

tarekcnn Post time 5 day(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-07-31 23:28
Reward10points

journalㄩJournal of Immunotherapy

AuthorsㄩMichiel C.T. van Zeijl; Jesper van Breeschoten; Liesbeth C. de Wreede; Michel W.J.M. Wouters; Doranne L. Hilarius; Christian U. Blank; Maureen J.B. Aarts; Franchette W.P.J. van den Berkmortel; Jan Willem B. de Groot; Geke A.P. Hospers; Ellen Kapiteijn; Djura Piersma; Rozemarijn S. van Rijn; Marion A. Stevense-den Boer; Astrid A.M. van der Veldt; Gerard Vreugdenhil; Marye J. Boers-Sonderen; Karijn P.M. Suijkerbuijk; John B.A.G. Haanen; Alfons J.M. van den Eertwegh

Published dateㄩ2023-6-

DOIㄩ10.1097/cji.0000000000000468

PDF linkㄩhttps://journals.lww.com/10.1097/CJI.0000000000000468

Article linkㄩhttps://doi.org/10.1097/cji.0000000000000468

Article SourceㄩOvid Technologies (Wolters Kluwer Health)


Remarkㄩ

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
pedroivogama Post time 5 day(s) ago | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Intermediate member
  • post

  • reply

  • points

    440


Return to the list